Approval · Notice of Compliance 16821 · 2015
AERIUS: Notice of Compliance 16821
Issued April 22, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16821
- Date
- April 22, 2015
- Company
- Bayer Inc Consumer CareMississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Changes to the product monograph
- Therapeutic class
- Histamine h1 receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AERIUS | 02243919 | Marketed |
| AERIUS KIDS | 02247193 | Marketed |
Medicinal ingredients
- DESLORATADINE 5 MG per TAB
- DESLORATADINE 0.5 MG per ML